Introduction {#sec1}
============

Fractured femur neck is a common presentation and arterial injury is a rare but recognized complication of proximal femur fractures.[@bib1], [@bib2], [@bib3], [@bib4] Most injuries are sub-clinical and radiological imaging is used to confirm the suspicion using duplex ultrasonography, computed tomography angiography (CTA), or angiography during the procedure. Depending on the anatomical characteristics and hemodynamic status of the patient, either an open or endovascular approach should be performed.[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10] This case reports a femoral fracture with delayed presentation of a deep femoral artery pseudoaneurysm (DFA-PSA) that was, at first confused with hematoma and initially presented with bleeding after orthopedic surgery. It was managed successfully with an endovascular stent graft after diagnosis.[@bib3], [@bib4], [@bib10]

Report {#sec2}
======

A 66 year old man presented with a fracture of the left femoral neck after falling. There was bruising in the left hip and thigh after the orthopedic surgery. Four months later, the patient was admitted to a general hospital for treatment of the hematoma, which was drained by the orthopedic team. Post-operatively, the patient developed bleeding and falling hematocrit. Image evaluation with arterial color Doppler and CTA confirmed the diagnosis of PSA. Doppler showed turbulent flow within the saccular structure with a wide communication with the DFA. CTA confirmed the presence of a 6.37 cm × 6.12 cm PSA in the DFA ([Fig. 1](#fig1){ref-type="fig"}). From a right common femoral artery puncture, a 6 Fr percutaneous Sheath Introducer was introduced, the left PFA was catheterized, and selective arteriography revealed an iatrogenic PSA ([Fig. 2](#fig2){ref-type="fig"}), which was successfully treated by stent graft repair. Two covered endovascular stent grafts (ADVANTA STENT Graft- 5 × 22 mm and 6 × 22 mm) were deployed into the feeding vessel with complete exclusion of the PSA ([Fig. 3](#fig3){ref-type="fig"}). PFA patency with no recurrence was confirmed at post-operative follow up by Duplex scan and CT ([Figure 4](#fig4){ref-type="fig"}, [Figure 5](#fig5){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"}).Figure 1From left to right, the red arrows show contrast CT scan with PSA. CTA confirmed the presence of a 6.37 cm × 6.12 cm PSA in the DFA.Figure 1Figure 2Angiography and filling of the superficial and DFA and the associated PSA (red arrow).Figure 2Figure 3From left to right, the stent graft position and angiography showing the final result after stenting deployment.Figure 3Figure 4Contrast CT scan with no PSA after treatment (red arrow).Figure 4Figure 53D angiotomography reconstruction showing PSA with lateral and anterior view (red arrow) from left to right, respectively.Figure 5Figure 6DFA with covered stents (blue arrow) best seen on 3D images.Figure 6

Discussion {#sec3}
==========

Injury to the DFA accounts for approximately 2% of peripheral arterial wounds.[@bib5], [@bib6] Undiagnosed complications include PSA and arteriovenous fistula.[@bib6] In cases of DFA in association with proximal femur fractures in orthopedic procedures, the possibility of PSA should be considered; however, no update based on trustworthy data has been published about this possibility. Only a few cases have been reported in the literature, analyzing a total of 131 cases of arterial PSAs and concluding that arteriography is the investigation of choice to confirm the diagnosis, while good options for treatment are embolization for small branch PSAs or stent grafts for PSAs originating from arterial trunks (as in the present case).[@bib7] Alternatively, surgical ligation or repair of PSAs is still an option.[@bib6], [@bib7] This is the treatment of choice in the presence of rupture, limb ischemia, or distal embolization.[@bib3] There are several other reports of DFA-PSAs being treated with various embolization techniques.[@bib6], [@bib8] Waldher et al. showed advances in endovascular procedures with embolic materials that made PSA treatment safe and efficient.[@bib8] Others agree that endovascular stent graft placement is safe,[@bib3], [@bib4], [@bib9], [@bib10] and this was therefore chosen as the most appropriate treatment option for the present case.

Endovascular grafting may be of particular value in patients with significant comorbid conditions such as older age, diabetic complications, cardiac or pulmonary dysfunction, and patients who are not considered good candidates for open surgery. Many physicians prefer the less invasive endovascular intervention in such cases.[@bib3], [@bib4], [@bib9], [@bib10]

In the present case, a covered stent was used to prevent flow into the pseudoaneurysm while maintaining vessel patency and DFA flow to the lower extremity. Two covered stents were necessary for the patient, showing trunk patency and complete exclusion of the PSA ([Figure 3](#fig3){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"}) as in the literature.[@bib3], [@bib4], [@bib9], [@bib10]

Another study published a series of six femoral PSAs with endografts in high risk patients after previous vascular surgery treated with stent graft implantation.[@bib10] That study concluded that femoral PSAs can be excluded successfully and that vessel occlusion is not expected.[@bib10] The present authors prefer an endovascular approach as endograft use has been well established based on anatomical and clinical parameters. Others have highlighted the decision to use covered stents suggested by the type of lesion and a large tear in the arterial wall.[@bib3]

The literature confirms the observations in this report in relation to the use of the stent graft; however, each case must be evaluated individually in the event of a rupture and decision making must be quicker so as not to endanger the patient\'s life. Conventional open procedures may yet provide a suitable and necessary option for treatment.

Pitfalls and limitations {#sec3.1}
------------------------

A surveillance program with appropriate management of possible in-stent intimal hyperplasia may improve the long-term patency.

Conclusion {#sec3.2}
----------

This case highlights the need for increased awareness of the possibility of PSA of the DFA in association with proximal femur fractures. Early outcome data from patients who underwent DFA revascularization with covered stents indicate that the procedure is safe with low complication rates.
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